AD
Ambra Constance M D
10% Owner

Ambra Constance M D insider trades: Albany Molecular Research (AMRI) stock buys and sales

10% Owner, Albany Molecular Research Last trade Nov 9, 2015 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2008
1
Company
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ambra reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 9, 2015AMRI↓ Sell$980K
Jun 10, 2015AMRI↓ Sell$395K
May 11, 2015AMRI↓ Sell$382K
Apr 10, 2015AMRI↓ Sell$370K
Mar 10, 2015AMRI↓ Sell$353K
Feb 10, 2015AMRI↓ Sell$338K
Jan 12, 2015AMRI↓ Sell$329K
Dec 10, 2014AMRI↓ Sell$325K
Nov 10, 2014AMRI↓ Sell$341K
Oct 10, 2014AMRI↓ Sell$432K
Sep 10, 2014AMRI↓ Sell$402K
Aug 11, 2014AMRI↓ Sell$380K
Jul 10, 2014AMRI↓ Sell$419K
Nov 15, 2012AMRI↑ Buy$38K
Nov 5, 2008AMRI↓ Sell$26K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ambra Constance M D's insider trades

Ambra Constance M D is a 10% owner of Albany Molecular Research (AMRI). Since Nov 5, 2008, Ambra has reported 1 open-market purchase worth $38K and 14 sales worth $5.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include gifts (14 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMRI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.